Halper Sadeh LLC Launches Investigations into Shareholder Rights for Major Companies

Halper Sadeh LLC Investigates Four Key Companies on Behalf of Shareholders

Halper Sadeh LLC, a prominent investor rights law firm, has initiated investigations into several major companies due to potential infringements of federal securities laws and breaches of fiduciary duties owed to their shareholders. The investigations extend to Hologic, Inc. (NASDAQ: HOLX), TrueCar, Inc. (NASDAQ: TRUE), PotlatchDeltic Corporation (NASDAQ: PCH), and Astria Therapeutics, Inc. (NASDAQ: ATXS). These inquiries aim to ensure that shareholders are informed about their rights and can pursue appropriate action if necessary.

Hologic, Inc. (HOLX)

One of the focal points of Halper Sadeh's investigation is Hologic, Inc., which has recently announced its sale to funds managed by Blackstone and TPG. Shareholders of Hologic were proposed to receive $76.00 per share in cash, complemented by a contingent value right that could yield up to an additional $3.00 in two installments of $1.50 each. This complex transaction raises questions about whether the offered compensation adequately reflects the company's value and if shareholders are positioned to benefit fully from the sale.

If you’re a shareholder of Hologic, it’s crucial to understand your rights and options regarding this transaction. Halper Sadeh LLC encourages those affected to engage with their legal team to explore potential options for recourse, including any increases to their compensation.

TrueCar, Inc. (TRUE)

Similarly, TrueCar is under scrutiny following its proposed sale to Fair Holdings, Inc., an entity led by one of its founders, Scott Painter. The proposed purchase price stands at $2.55 per share. As a TrueCar shareholder, it’s vital to ascertain whether this price is equitable and reflects the full value of your investment. Halper Sadeh LLC is prepared to offer guidance regarding your legal rights related to this sale, advocating for better terms wherever possible.

PotlatchDeltic Corporation (PCH)

Next, Halper Sadeh has turned its attention to PotlatchDeltic Corporation, which is set to be acquired by Rayonier Inc. under a plan where PotlatchDeltic shareholders will receive 1.7339 common shares of Rayonier for each share they currently hold. This structure means that existing shareholders will own about 46% of the newly combined company. The investigators are particularly interested in examining whether this structure is favorable for PotlatchDeltic shareholders and if they are getting a fair deal in exchange for their shares.

As with the previous cases, those holding shares in PotlatchDeltic should clarify their rights and be aware of their options by contacting Halper Sadeh LLC for further insights.

Astria Therapeutics, Inc. (ATXS)

Finally, Astria Therapeutics is also being investigated due to its agreement to be acquired by BioCryst Pharmaceuticals, Inc. The details of this transaction involve a cash payment of $8.55 per share along with 0.59 shares of BioCryst common stock for each share of Astria. Given the complexities of this transaction, it is essential for shareholders of Astria to consider whether they are receiving a fair value for their equity and whether additional disclosures are warranted.

Halper Sadeh LLC's investigations represent a commitment to ensuring that shareholders' interests are protected during these significant corporate transitions. The firm emphasizes that shareholders will not incur any out-of-pocket expenses related to these inquiries, as they operate on a contingent fee basis. This reassurance allows shareholders to pursue their rights without financial risk.

What Should You Do?

If you are a stakeholder in any of these companies or know someone who is, it’s imperative to get in touch with Halper Sadeh LLC at (212) 763-0060 or via emails to both Daniel Sadeh and Zachary Halper at [email protected] and [email protected] respectively. Engaging with them can provide essential insights into your rights and potential courses of action regarding these transactions. Protecting your investment is paramount, and timely legal counsel could enhance the outcomes you achieve from these transactions.

In an environment of corporate acquisitions, vigilance is vital. Stay informed and proactive in defending your shareholder rights.